Rare Presentation of a Relapsing Remitting Central Nervous System Vasculitis: A Case Report.

Maksymilian Brzezicki; Matthew Kobetic; Dillon Serena

doi:10.1055/a-0743-5558

Fortschritte der Neurologie · Psychiatrie, Inhaltsverzeichnis

Fortschr Neurol Psychiatr 2019; 87(02): 129-132
DOI: 10.1055/a-0743-5558

Kasuistik

Rare Presentation of a Relapsing Remitting Central Nervous System Vasculitis: A Case Report.

Seltene Präsentation eines schubförmig remittierender Zentralnervensystem Vaskulitis - Fallbericht.

Maksymilian Brzezicki

¹Bristol Institute of Clinical Neurosciences, Southmead Hospital; University of Oxford Nuffield Department of Clinical Neurosciences

,

Matthew Kobetic

²University of Bristol, Faculty of Health Sciences

,

Dillon Serena

³University of Oxford Nuffield Department of Clinical Neurosciences

› Institutsangaben

Abstract

Zusammenfassung

Wir berichten über einen interessanten Fall einer Vaskulitis des zentralen Nervensystems, der eine schubförmig-remittierende Natur und ein bisher nicht berichtetes Profil kognitiver Defizite bei dieser Variante der Erkrankung aufweist.

Der Patient stellte sich mit beidseitigem Kopfschmerz, Gesichtsfeldverlust des linken Auges, Dyschromatopsie und vorübergehender Bewusstlosigkeit vor. Er wurde in den letzten acht Jahren auf ähnliche Symptome untersucht. Es gab eine klare schubförmig-remittierende Geschichte, mit Perioden voller Remission von 4-6 Monaten.

MRT-Untersuchungen zeigten bilaterale Bereiche von Hyperintensitäten, repräsentativ für kleine „nicht-charakteristische“ Veränderungen, wahrscheinlich vaskulären Ursprungs.

In diesem Bericht wird die klinische Konundra während der Evaluation des Patienten diskutiert, mögliche Differentialdiagnosen untersucht und über die hypothetische Rolle der Statinverwendung in ähnlichen Fällen kommentiert.

Abstract

We report an interesting case of a central nervous system vasculitis, presenting with a relapsing remitting nature and a previously unreported profile of cognitive deficits in this variant of the disease.

The patient presented with bilateral headache, left eye upper temporal quarter visual field loss, dyschromatopsia and a transient loss of consciousness. He was previously evaluated for similar set of symptoms over the past eight years. There was a clear relapsing-remitting history, with periods of full remission of 4-6 months.

MR studies showed bilateral areas of hyperintensities, representative of small “non-characteristic” changes, likely of a vascular origin.

The case discusses clinical conundra during the patient’s evaluation, examines possible differential diagnoses and comments on the hypothesised role of statin use in similar cases.

Schlüsselwörter

Differenzialdiagnose - kognitive Neurologie - vaskuläre Neurologie - Akut-Neurologie - Vaskulitis

Key words

differential diagnosis - cognitive neurology - vascular neurology - acute neurology - vasculitis

Volltext

Referenzen

Literatur
1 Lally L, Sammaritano LR. Vasculitis in Antiphospholipid Syndrome. Rheum. Dis. Clin. 2015; 41: 109-123 .
2 Hajj-Ali Rula A, Furlan Anthony, Abou-Chebel Alex. , et al. Benign angiopathy of the central nervous system: Cohort of 16 patients with clinical course and long-term followup. Arthritis Care Res. 2002; 47: 662-669 .
3 Calabrese LH, Mallek JA. Primary angiitis of the central nervous system. Report of 8 new cases, review of the literature, and proposal for diagnostic criteria. Medicine (Baltimore). 1988; 67: 20-39 .
4 Lancaster E. The Diagnosis and Treatment of Autoimmune Encephalitis. J. Clin. Neurol. Seoul Korea. 2016; 12: 1-13 .
5 Tohid H. Anti-glutamic acid decarboxylase antibody positive neurological syndromes. Neurosciences. 2016; 21: 215-222 .
6 Berger T, Rubner P, Schautzer F. , et al. Antimyelin Antibodies as a Predictor of Clinically Definite Multiple Sclerosis after a First Demyelinating Event. N. Engl. J. Med. 2003; 349: 139-145 .
7 Pröbstel A-K, Rudolf G, Dornmair K. , et al. Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype. J. Neuroinflammation [Internet]. 2015 [cited 2018 Jun 12];12. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359547 /.
8 NICE, National Institute of Healthcare Excellence. Stroke and transient ischaemic attack in over 16s: diagnosis and initial management. Clinical Guideline CG68 [Internet]. 2017 [cited 2018 Apr 18]. Available from: https://www.nice.org.uk/guidance/cg68 .
9 Lyden P, Brott T, Tilley B. , et al. Improved reliability of the NIH Stroke Scale using video training. NINDS TPA Stroke Study Group. Stroke. 1994; 25: 2220-2226 .
10 Salvarani C, Brown RD, Calamia KT. , et al. Primary central nervous system vasculitis: analysis of 101 patients. Ann. Neurol. 2007; 62: 442-451 .
11 Hajj-Ali RA, Singhal AB, Benseler S. , et al. Primary angiitis of the CNS. Lancet Neurol. 2011; 10: 561-572 .
12 Chong JY. Cerebrovascular Disease. 1. edition. Oxford New York: Oxford University Press; 2013. .
13 Powers WJ. Primary Angiitis of the Central Nervous System: Diagnostic Criteria. Neurol. Clin. 2015; 33: 515-526 .
14 Julayanont P, Phillips N, Chertkow H. , et al. Montreal Cognitive Assessment (MoCA): Concept and Clinical Review. Cogn. Screen. Instrum. [Internet]. Springer; , London: 2013. [cited 2017 Nov 18]. p. 111-151 . Available from: https://link.springer.com/chapter/10.1007/978-1-4471-2452-8_6 .
15 Borst JP, Anderson JR. Using model-based functional MRI to locate working memory updates and declarative memory retrievals in the fronto-parietal network. Proc. Natl. Acad. Sci. U. S. A. 2013; 110: 1628-1633 .
16 Thomas SA. Neuromodulatory signaling in hippocampus-dependent memory retrieval. Hippocampus. 2015; 25: 415-431 .
17 Opitz B. Memory function and the hippocampus. Front. Neurol. Neurosci. 2014; 34: 51-59 .
18 Pinchuk TV, Fedulaev YN, Khairetdinova GA. , et al. Anti-inflammatory effects of simvastatin in patients with chronic heart failure. Bull. Exp. Biol. Med. 2014; 157: 552-554 .
19 Kirmizis D, Papagianni A, Dogrammatzi F. , et al. Anti-inflammatory effects of simvastatin in diabetic compared to non-diabetic patients on chronic hemodialysis. J. Diabetes. 2013; 5: 492-494 .
20 Stein A, Stroobants S, Gieselmann V. , et al. Anti-inflammatory Therapy With Simvastatin Improves Neuroinflammation and CNS Function in a Mouse Model of Metachromatic Leukodystrophy. Mol. Ther. 2015; 23: 1160-1168 .